Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Older Who Have at Least One F508del Mutation
.
Show all posts
Showing posts with label
Older Who Have at Least One F508del Mutation
.
Show all posts
Saturday, March 14, 2020
FDA Approves Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for Cystic Fibrosis Patients Ages 12 and Older Who Have at Least One F508del Mutation
›
In continuation of my update on tezacaftor and ivacaftor Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the...
›
Home
View web version
